Alex Ridout on FemTech

episode

The Lancet Obstetrics, Gynaecology, & Women’s Health not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Who'll benefit from budget? 14 min · 29 Sep 2026 · Today with David McCullagh

Wall Street Veteran: The Bond Sell-Off Is A Buying Opportunity 37 min · 29 Sep 2026 · Prof G Markets

BONUS POD: The Fraud Epidemic: Trump's DOJ Targets Billions in Stolen Tax Dollars 14 min · 29 Sep 2026 · Verdict with Ted Cruz

NPR News: 09-29-2026 4AM EDT 5 min · 29 Sep 2026 · NPR News Now

Media Power, College Sports, and Crypto 18 min · 29 Sep 2026 · The Politics Guys

QUESTA - Act 2 42 min · 29 Sep 2026 · Table Read

Report any issue

Source

Recorded09 Feb 2026

Publisherfeeds.buzzsprout.com

Handlerec:15819263

Show notes

From its origins in fertility medicine and wellness, the field of FemTech is rapidly evolving, with new innovations having the potential to drastically improve the health of women and girls in low-income and middle-income countries. However, barriers exist preventing the true potential of FemTech interventions to be realised. Alex Ridout (King's College London, London, UK) joins Ben to discuss the potential FemTech offers and the hurdles preventing its role out. Click here to read the full article: https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(25)00125-6/fulltext

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in